Mechanisms of resistance to the BCR-ABL1 allosteric inhibitor asciminib

Leukemia. 2017 Dec;31(12):2844-2847. doi: 10.1038/leu.2017.264. Epub 2017 Aug 18.

W Qiang^{1

2}, O Antelope², M S Zabriskie², A D Pomicter², N A Vellore², P Szankasi³, D Rea⁴, J M Cayuela⁵, T W Kelley^{3

6}, M W Deininger^{2

7}, T O'Hare^{2

7}

¹ Department of Hematology, Nanfang Hospital, Southern Medical University, GuangZhou, China.
² Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
³ ARUP Laboratories, Salt Lake City, UT, USA.
⁴ Service d'Hématologie Adulte and INSERM UMR1160, Hospital Saint-Louis, Paris, France.
⁵ Laboratory of Hematology, University Hospital Saint- Louis and EA3518, University Paris Diderot, Paris.
⁶ Department of Pathology, University of Utah, Salt Lake City, UT, USA.
⁷ Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA.

No abstract available

Publication types